Vivo Opportunity, LLC

Insider Reports History

Location
192 Lytton Avenue, Palo Alto, CA
Signature
VIVO OPPORTUNITY, LLC, By: /s/ Kevin Dai
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Vivo Opportunity, LLC:

Stock Role Class Num Shares Value Price $ Report Date Ownership
SOLENO THERAPEUTICS INC 10%+ Owner Common Stock 4.46M $315M $70.60 Mar 28, 2025 By Vivo Opportunity Fund Holdings, L.P.
Terns Pharmaceuticals, Inc. 10%+ Owner Common Stock 4.02M $24.9M $6.20 Apr 3, 2024 By Vivo Opportunity Fund Holdings, L.P.
Terns Pharmaceuticals, Inc. 10%+ Owner Common Stock 1.95M $12.1M $6.20 Apr 3, 2024 By: Vivo Capital Fund VIII, L.P.
Terns Pharmaceuticals, Inc. 10%+ Owner Common Stock 269K $1.67M $6.20 Apr 3, 2024 By: Vivo Capital Surplus Fund VIII, L.P.
Sierra Oncology, Inc. Director, 10%+ Owner Common Stock 0 $55.00 Jul 1, 2022 By: Vivo Capital Fund IX, L.P.
Sierra Oncology, Inc. Director, 10%+ Owner Common Stock 0 $55.00 Jul 1, 2022 By: Vivo Opportunity Fund Holdings, L.P.
Sierra Oncology, Inc. Director, 10%+ Owner Common Stock 0 $55.00 Jul 1, 2022 By: Vivo Ventures Fund VII, L.P. and Vivo Ventures VII Affiliates Fund, L.P.
Sierra Oncology, Inc. Director, 10%+ Owner Series A Warrants 0 Jul 1, 2022 By: Vivo Capital Fund IX, L.P.
Sierra Oncology, Inc. Director, 10%+ Owner Series A Warrants 0 Jul 1, 2022 By: Vivo Opportunity Fund Holdings, L.P.
Sierra Oncology, Inc. Director, 10%+ Owner Series A Warrants 0 Jul 1, 2022 By: Vivo Ventures Fund VII, L.P. and Vivo Ventures VII Affiliates Fund, L.P.
Sierra Oncology, Inc. Director, 10%+ Owner Series B Warrant (Right to Purchase ) 0 Jan 26, 2022 By: Vivo Capital Fund IX, L.P.
Sierra Oncology, Inc. Director, 10%+ Owner Series B Warrant (Right to Purchase ) 0 Jan 26, 2022 By: Vivo Opportunity Fund, L.P.
Sierra Oncology, Inc. Director, 10%+ Owner Series B Warrant (Right to Purchase ) 0 Jan 26, 2022 By: Vivo Ventures Fund VII, L.P. and Vivo Ventures VII Affiliates Fund, L.P.

Insider Reports Filed by Vivo Opportunity, LLC

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SLNO SOLENO THERAPEUTICS INC Mar 26, 2025 3 -$124M 4 Mar 28, 2025 10%+ Owner
SLNO SOLENO THERAPEUTICS INC Aug 27, 2024 3 -$49.2M 4 Aug 29, 2024 10%+ Owner
SLNO SOLENO THERAPEUTICS INC Apr 29, 2024 2 -$51.7M 4 May 1, 2024 10%+ Owner
TERN Terns Pharmaceuticals, Inc. Apr 1, 2024 9 -$2.8M 4 Apr 3, 2024 10%+ Owner
SLNO SOLENO THERAPEUTICS INC Oct 2, 2023 2 $13M 4 Oct 4, 2023 10%+ Owner
SLNO SOLENO THERAPEUTICS INC Sep 26, 2023 2 $5.61M 4 Sep 28, 2023 10%+ Owner
SLNO SOLENO THERAPEUTICS INC May 8, 2023 0 $0 3 May 15, 2023 10%+ Owner
TERN Terns Pharmaceuticals, Inc. Dec 23, 2022 1 $5.5M 4 Dec 23, 2022 10%+ Owner
TERN Terns Pharmaceuticals, Inc. Sep 7, 2022 1 $2.16M 4 Sep 8, 2022 10%+ Owner
TERN Terns Pharmaceuticals, Inc. Aug 12, 2022 4 $10.6M 4 Aug 16, 2022 10%+ Owner
SRRA Sierra Oncology, Inc. Jul 1, 2022 6 -$183M 4 Jul 1, 2022 Director, 10%+ Owner
SRRA Sierra Oncology, Inc. Jan 31, 2022 1 $21.6M 4 Jan 31, 2022 10%+ Owner
SRRA Sierra Oncology, Inc. Jan 26, 2022 6 -$16.4M 4 Jan 28, 2022 10%+ Owner